N-Caffeoyl serotonin as selective COX-2 inhibitor

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Biochemistry

Background:

• Cyclooxygenase (COX) enzymes play a crucial role in inflammation.
• Selective inhibition of COX-2 is a therapeutic target for anti-inflammatory drugs.
• Serotonin derivatives are explored for their pharmacological activities.

Purpose of the Study:

• To evaluate the cyclooxygenase (COX) inhibitory effects of synthetic serotonin analogues.
• To identify specific structural features responsible for COX inhibition.
• To assess the potential of these compounds as anti-inflammatory agents.

Main Methods:

• Synthesis of eight serotonin analogues.
• In vitro evaluation of COX-1 and COX-2 inhibition.
• Structure-activity relationship analysis comparing derivatives with parent compounds like caffeic acid.

Main Results:

• Two serotonin derivatives (4 and 8) demonstrated inhibitory effects on both COX-1 and COX-2.
• Compound 4 exhibited potent and selective inhibition of COX-2 (IC50 = 42.5 μM).
• The combination of caffeic acid and serotonin moieties in compound 4 enhanced COX-2 selectivity compared to aspirin and caffeic acid alone.

Conclusions:

• The catechol moiety in cinnamic acid derivatives is critical for selective COX-2 inhibition.
• Compound 4, N-caffeoyl serotonin, shows significant selective COX-2 inhibitory activity.
• These findings suggest compound 4 as a promising candidate for developing drugs targeting inflammatory and allergic diseases.